Keyword: CRT Pioneer Fund
Azeria Therapeutics has raised £32 million ($41 million) to take its estrogen receptor positive breast cancer program into the clinic.
LifeArc has set up a seed fund to invest in early preclinical projects that are overlooked because of the high risk of failure at that stage of R&D.
Cancer Research UK has teamed up with the National Cancer Institute to fund work on inhibitors of Ras proteins.
A clutch of leading U.K. life sciences investors is pooling its resources to create a group with £1 billion ($1.2 billion) in assets.